 NEW YORK--BUSINESS WIRE--Attorney Advertising-- Bronstein, Gewirtz Grossman, LLC is investigating potential claims on behalf of purchasers of Brainstorm Cell Therapeutics Inc. Brainstorm or the Company NASDAQ: BCLI. Investors who purchased Brainstorm securities are encouraged to obtain additional information and assist the investigation by visiting the firms site: The investigation concerns whether Brainstorm and certain of its officers andor directors hav 